Article

Survey captures snapshot of astigmatism

The 2013 ASCRS Clinical Survey Results on Astigmatism-covering 168 data points with more than 1,000 physicians responding-showed that 57% of physicians saw benefits associated with femtosecond laser arcuate incisions compared with conventional manual incisions, according to John A. Vukich, MD.

Boston-The 2013 ASCRS Clinical Survey Results on Astigmatism-covering 168 data points with more than 1,000 physicians responding-showed that 57% of physicians saw benefits associated with femtosecond laser arcuate incisions compared with conventional manual incisions, according to John A. Vukich, MD.

"The arcuate incisions stood out as the one area where there was some feeling that they would provide a clinical benefit," said Dr. Vukich, in private practice in Madison, WI.

Regarding multifocal IOLs, 45% indicated that up to 0.71 D of residual cylinder was acceptable after implantation before visual function was affected; 0.61 D of postoperative sphere was considered acceptable, with 35% claiming that 0.75 D was acceptable before vision was compromised.

Regarding the acceptance of presbyopia-correcting IOLs to treat substantial residual cylinder, 51% of respondents use laser vision correction. U.S. physicians were far more likely to use astigmatic keratotomy limbal-relaxing incisions compared with European physicians; while 16% of respondents prefer glasses or contacts.

 

Regarding toric IOLs, only about 25% of respondents use them, with only about 15% in the United States. Regarding the accuracy of centration of these IOLs, most respondents thought that an average of 7° of decentration had to be present before there was a visual problem, while 33% claimed that up to 10° off the intended axisbefore there was a problem. When using a toric IOL, the survey identified a 50/50 split on whether to flip the axis to aim for lower residual astigmatism levels or stay within the original axis.

There was no consensus regarding the diagnostics to use for power decisions or for axis decisions, he said.

"The survey found enthusiam for femtosecond laser incisions," Dr. Vukich summarized. "There were high levels of acceptable residual pseudophakic error after implantation of multifocal IOLs. There were high levels of acceptable rotational error in the intended axis for toric IOL patients. There was no consensus on flipping the axis or on the use of diagnostic devices. There was high confidence in laser vision correction."

For more articles in this issue of Ophthalmology Times’ Conference Brief, click here.

 

 

 

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times)  ASCRS 2025: Joaquin De Rojas, MD, leverages machine learning model to predict arcuate outcomes
(Image credit: Ophthalmology Times) ASCRS 2025: AnnMarie Hipsley, DPT, PhD, presents VESA for biomechanical simulation of presbyopia progression
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
© 2025 MJH Life Sciences

All rights reserved.